SCHEMBL4205443

SCHEMBL4205443

C[C@H]1COC[C@H](C)N1c1cc(CS(=O)(=O)c2ccccc2)nc(Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
ALDH1A1 P00352 7/20 0.45
HTT P42858 4/20 0.45
LMNA P02545 3/20 0.45
PIK3CA P42336 3/20 0.45
MTOR P42345 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MCL1 Q07820 1/20 0.41
NSD2 O96028 1/20 0.39
G6PD P11413 1/20 0.39
CCR6 P51684 1/20 0.39
NPSR1 Q6W5P4 2/20 0.37
PIK3CD O00329 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3923572 1.00 POLB (0.46) POLBALDH1A1HTTLMNAPIK3CA
SCHEMBL739607 0.86 PIK3CA (0.52) POLBALDH1A1HTTLMNAPIK3CA
SCHEMBL4195965 0.83 PIK3CA (0.44) POLBPIK3CAMTORNSD2G6PD
SCHEMBL4200787 0.81 POLB (0.36) POLBPIK3CAMTORNSD2G6PD
SCHEMBL3927579 0.81 POLB (0.36) POLBPIK3CAMTORNSD2G6PD
SCHEMBL4211899 0.79 POLB (0.53) POLBALDH1A1HTTLMNAPIK3CA
SCHEMBL3600075 0.78 MTOR (0.67) POLBALDH1A1HTTLMNAPIK3CA
SCHEMBL4201583 0.78 PIK3CA (0.50) POLBPIK3CAMTORPIK3CD
SCHEMBL3596530 0.78 POLB (0.59) POLBALDH1A1HTTLMNAPIK3CA
SCHEMBL3595007 0.77 ATR (0.50) POLBALDH1A1HTTLMNAPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018134-A1 Compounds - 945 ASTRAZENECA AB (SE) 2009-01-15 US disclosed
US-20090018134-A1 Compounds - 945 ASTRAZENECA AB (SE) 2009-01-15 US disclosed
US-20090018134-A1 Compounds - 945 ASTRAZENECA AB (SE) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018134-A1 Compounds - 945 MTOR, PIK3CA, PIK3R5 POLB 841/4885ALDH1A1 2861/4885HTT 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.